Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NWS Anticoagulation After EVL in Cirrhotic PVT Patients
NCT04976543Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Feb 2020
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nadroparin, warfarin in portal vein thrombosis (PVT), sponsored by Qilu Hospital of Shandong University. Started Feb 2020; status: completed.
02
Drugs
nadroparinwarfarin
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT04976543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976543.